Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2391814
Max Phase: Preclinical
Molecular Formula: C34H40F6N4O5
Molecular Weight: 454.66
Molecule Type: Small molecule
Associated Items:
ID: ALA2391814
Max Phase: Preclinical
Molecular Formula: C34H40F6N4O5
Molecular Weight: 454.66
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN1CCCCCN(C)c2cc[n+](c3ccccc23)CCCCC[n+]2ccc1c1ccccc12.O.O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F
Standard InChI: InChI=1S/C30H38N4.2C2HF3O2.H2O/c1-31-19-9-3-10-20-32(2)28-18-24-34(30-16-8-6-14-26(28)30)22-12-4-11-21-33-23-17-27(31)25-13-5-7-15-29(25)33;2*3-2(4,5)1(6)7;/h5-8,13-18,23-24H,3-4,9-12,19-22H2,1-2H3;2*(H,6,7);1H2/q+2;;;/p-2
Standard InChI Key: WFARNUKBOZYNTR-UHFFFAOYSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 454.66 | Molecular Weight (Monoisotopic): 454.3086 | AlogP: 5.49 | #Rotatable Bonds: 0 |
Polar Surface Area: 14.24 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -2.42 | CX LogD: -2.42 |
Aromatic Rings: 4 | Heavy Atoms: 34 | QED Weighted: 0.33 | Np Likeness Score: -0.01 |
1. Yang D, Arifhodzic L, Ganellin CR, Jenkinson DH.. (2013) Further studies on bis-charged tetraazacyclophanes as potent inhibitors of small conductance Ca(2+)-activated K+ channels., 63 [PMID:23685886] [10.1016/j.ejmech.2013.02.029] |
Source(1):